Basic Inderal La Information

• INN (International Nonproprietary Name): propranolol hydrochloride
• Brand Names Available In Canada (English): Inderal LA; generics of propranolol extended-release (brand availability may vary by pharmacy)
• ATC Code: C07AA05
• Forms & Dosages: Extended-release capsules (LA/XL) — 60 mg, 80 mg, 120 mg, 160 mg; Standard tablets commonly 10 mg, 40 mg, 80 mg
• Manufacturers In Canada (English): not specified
• Registration Status In Canada (English): not specified
• OTC / Rx Classification: Prescription-only (Rx)

Availability & Price Landscape

Worried about where to find Inderal LA or a generic propranolol LA in your province?

Major national pharmacy chains commonly stock propranolol extended-release generics and can often special-order brand product when requested.

Shoppers Drug Mart, Rexall and London Drugs are among the chains most likely to carry generic propranolol LA, with some locations able to order brand Inderal LA on request.

Jean Coutu commonly services Quebec patients and typically stocks generics while arranging brand orders when required.

Short List — Brand vs Generic Availability:

• Generics commonly stocked: Shoppers Drug Mart, Rexall, London Drugs, Jean Coutu (QC).
• Brand Inderal LA: may be special‑ordered at the above chains; availability varies by location.

Online pharmacy trends are shaped by provincial regulatory rules that control dispensing and shipping across provincial borders.

Some provincial pharmacies will not ship prescriptions out of province, and patients often compare in‑store dispensing fees with online prices before ordering.

Cross‑border sourcing from the United States remains common for cost savings but it carries regulatory and import risks.

Price ranges for propranolol LA vary with strength, pack size and provincial formulary coverage.

As an example, generic propranolol LA 80 mg, 30 capsules typically ranges from about CAD 15 to CAD 50 depending on the pharmacy and province.

Brand Inderal LA tends to cost more, often CAD 60 or higher for a similar pack size when available.

Remember that provincial drug plans and private insurance commonly offset out‑of‑pocket costs, and prescription status may affect dispensing fees.

Canadian Patient Insights & Satisfaction Levels

Are Canadians finding Inderal LA effective and affordable?

Canadian patients share experiences on platforms such as Reddit Canada, HealthBoards and provincial health forums when discussing propranolol LA.

Common positive themes include clear reductions in migraine frequency and reliable tremor control with once‑daily extended‑release dosing.

Many patients praise the convenience of LA/XL formulations for steady symptom control and adherence compared with multiple daily doses of immediate‑release tablets.

Reported challenges include daytime fatigue, vivid dreams or sleep disturbances that some patients link to propranolol’s central effects.

Access and cost concerns are frequent in provinces where formulary listings require prior authorizations or copayments under programs like BC PharmaCare or Ontario Drug Benefit (ODB).

Patient Quote Example: "Once my dose was stable on the LA capsule I saw fewer migraines, but it took weeks to get the right dose and I felt more tired for a while."

Practical patient tips from Canadian users include discussing dose adjustments with the prescriber and asking the pharmacist to confirm generic interchangeability and DIN numbers before accepting a substitution.

Checklist Before Pickup:

• Confirm indication and dose with prescriber.
• Ask pharmacist for DIN and manufacturer when switching brands.
• Compare in‑store dispensing fees and online total costs.

Product Overview & Brand Variants

What exactly is propranolol hydrochloride and which strengths are commonly used?

The INN is propranolol hydrochloride and the ATC code is C07AA05, classifying it as a non‑selective beta‑blocking agent.

Worldwide packaging lists brand names such as Inderal LA, Inderal XL and InnoPran XL, alongside multiple generics supplied by several manufacturers.

Extended‑release capsule strengths commonly available internationally include 60 mg, 80 mg, 120 mg and 160 mg.

Standard immediate‑release tablets commonly come in strengths such as 10 mg, 40 mg and 80 mg depending on brand.

Inderal LA and generic propranolol extended‑release are prescription‑only across Canada and have Health Canada oversight via Drug Identification Numbers (DINs).

Pharmacists should verify the DIN on the packaging to confirm the exact formulation and to access the DIN‑specific product monograph before dispensing.

Packaging and capsule colour can vary by manufacturer and may not match U.S. colour codes.

Indications In Local Canadian Medical Practice

What do Canadian prescribers use propranolol LA for?

Typical Health Canada‑relevant indications for propranolol LA include hypertension, angina, certain arrhythmias, migraine prophylaxis and essential tremor.

Initial adult dosing commonly starts at 80 mg LA once daily for many indications, with maintenance often in the 120–160 mg once‑daily range.

For migraine prophylaxis maintenance, doses of 160–240 mg per day are used under specialist guidance when required.

Off‑label uses in Canadian practice may include performance anxiety or some PTSD‑related symptom management, usually under specialist care and with documented rationale.

Extended‑release formulations are less commonly used in children and require specialist, weight‑based dosing if considered.

Prescribers typically check provincial formularies such as ODB, BC PharmaCare or RAMQ for coverage criteria and may request prior authorizations for higher doses or brand products.

How It Works In The Body

How does propranolol LA reduce migraines, tremor and blood pressure?

Propranolol hydrochloride is a non‑selective beta‑blocker that reduces heart rate and cardiac contractility by blocking beta‑adrenergic receptors.

Blocking these receptors lowers blood pressure and calms overactive sympathetic signalling, which helps prevent migraine attacks and reduces tremor amplitude.

Propranolol crosses the blood–brain barrier, which contributes to central nervous system effects such as vivid dreams or mood changes in susceptible patients.

Extended‑release LA/XL formulations provide steadier plasma concentrations over 24 hours compared with immediate‑release forms, supporting once‑daily dosing and more stable symptom control.

The ATC classification C07AA05 reflects its status among non‑selective beta‑blocking agents.

For pharmacokinetic specifics like metabolism and elimination, pharmacists should consult the DIN‑linked product monograph for the manufacturer‑specific data.

Dosage & Administration

What is the usual dosing routine and how should patients take Inderal LA?

Adults often start Inderal LA/XL at 80 mg once daily, with maintenance commonly 120–160 mg once daily for hypertension or angina.

Migraine prophylaxis maintenance doses frequently fall between 160 and 240 mg per day under specialist direction and monitoring.

When higher doses are used for arrhythmias or tremor, regimens may be divided; follow the prescriber’s instructions and the product monograph.

Take LA capsules at the same time every day and swallow whole; do not crush or chew the extended‑release capsule.

If a dose is missed, take it as soon as remembered unless it is near the next dose — do not double doses.

Elderly patients should start at lower doses and titrate slowly due to increased sensitivity.

Hepatic impairment calls for dose caution because propranolol undergoes hepatic metabolism.

Pharmacists should confirm the prescription specifies LA/XL if once‑daily dosing is intended and provide counselling on titration schedules.

Contraindications & Side Effects

Who should not take Inderal LA and what side effects should patients expect?

Absolute contraindications include asthma or bronchospastic disease, severe bradycardia, second or third‑degree AV block without a pacemaker, uncompensated heart failure and known hypersensitivity to propranolol.

Common side effects are fatigue, dizziness, bradycardia, hypotension, sleep disturbances such as vivid dreams, and gastrointestinal upset.

Less common but important effects include depression, sexual dysfunction and cold extremities.

Serious but rare reactions include severe bronchospasm in patients with reactive airways disease and profound bradyarrhythmias; overdose can lead to severe hypotension and cardiac arrest.

Patients with diabetes should be counselled that beta‑blockers can mask signs of hypoglycaemia.

Report serious adverse events to Health Canada’s Canada Vigilance Program and include the DIN and lot number when possible.

Comparable Medicines In Canada

What are reasonable alternatives if propranolol LA is unsuitable?

Alternatives include cardioselective beta‑blockers such as atenolol, metoprolol (including extended‑release metoprolol formulations) and bisoprolol, and agents like carvedilol in heart‑failure settings.

Pros and Cons Summary:

• Propranolol LA — pro: effective for migraine and tremor, once‑daily dosing, widely available generics; con: greater CNS penetration and contraindicated in asthma.
• Metoprolol/Atenolol — pro: cardioselective with fewer pulmonary risks; con: may be less effective for tremor or some migraine patients.
• Carvedilol — pro: beneficial in heart failure; con: different side‑effect profile and dosing complexity.

When switching, match total daily beta‑blocker effect and monitor blood pressure and heart rate closely, following prescriber guidance.

Current Research & Trends

What recent studies and trends affect how Inderal LA is used?

Recent international and Canadian research (2022–2025) has focused on propranolol’s role in migraine prevention, performance anxiety interventions and real‑world tolerability in older adults.

Investigators in Canada contribute observational studies and registry analyses comparing tolerability and outcomes in routine care populations.

Interest persists in whether extended‑release formulations improve adherence and reduce peak‑related side effects compared with immediate‑release dosing.

Emerging evidence supports the benefit of LA/XL for adherence and migraine prevention in many patients, while cardioselective alternatives may be better tolerated in those prone to CNS effects.

Ongoing trials aim to clarify optimal dosing ranges for migraine and tremor and to compare patient‑reported outcomes across formulations.

Common Patient Questions In Canada

What do Canadians ask most about Inderal LA when they call the pharmacy?

Is Inderal LA prescription‑only in Canada?

Yes — propranolol extended‑release is prescription‑only; check the DIN on the bottle or package.

Will my provincial plan cover Inderal LA?

Coverage varies by province and by DIN; check ODB in Ontario, BC PharmaCare, RAMQ in Quebec or private plans for criteria and prior‑authorisation rules.

Can I fly with my medication across provinces or to the United States?

Domestic travel is allowed with prescription documentation, but cross‑border travel introduces import limits and regulatory differences—carry the original prescription and check CBSA rules.

Can I stop suddenly?

No — abrupt discontinuation can cause rebound tachycardia or angina; taper as directed by the prescriber.

What interactions should I watch for?

Propranolol interacts with other antihypertensives and drugs that affect hepatic metabolism; review all medications with the pharmacist.

Regulatory Status

How does Health Canada regulate Inderal LA and why does the DIN matter?

Health Canada evaluates safety, efficacy and quality before authorising products for the Canadian market and assigns a Drug Identification Number (DIN) to each marketed product.

The DIN uniquely identifies formulation, strength and manufacturer and helps pharmacists confirm they are dispensing the correct LA/XL product rather than an immediate‑release tablet.

Provincial formularies use DIN‑specific assessments to determine listing, prior‑authorisation requirements and reimbursement details.

For pharmacovigilance, pharmacies should record the DIN and lot number when reporting suspected adverse reactions to Canada Vigilance.

Visual Recommendations

Which quick visuals help patients understand Inderal LA on a product page?

Include a dosage chart that shows starting and maintenance doses by indication with a clear footnote to consult the prescriber and the product monograph.

A shelf card that lists DIN, manufacturer, batch and expiry paired with provincial formulary icons (ODB, PharmaCare, RAMQ) helps customers at a glance.

A pharmacokinetic comparison graph that contrasts steady LA plasma levels with peaks and troughs of immediate‑release dosing clarifies once‑daily benefits.

A counselling infographic with bold icons for contraindications, common side effects, the “do not stop abruptly” message and travel/storage tips increases safe use.

Ensure visuals use clear fonts and bilingual labels where required in Québec and follow Health Canada legibility guidance.

Buying & Storage Advice

How should Canadians buy and store Inderal LA safely?

In‑store purchases let patients confirm DIN, manufacturer and formulation with a pharmacist and may provide same‑day pickup for generics.

When ordering online, choose a licensed Canadian pharmacy with a verifiable physical address and a pharmacist contact, and check provincial shipping restrictions.

Be cautious with cross‑border suppliers that bypass Health Canada oversight.

In our online pharmacy, inderal la is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Store propranolol at room temperature 15–30 °C (59–86 °F) and protect it from moisture and light.

Avoid leaving medication in vehicles during Canadian winter cold or summer heat to prevent freezing or heat damage.

Dispose of unused or expired propranolol via local pharmacy take‑back programs; do not flush medications down sinks or toilets.

Guidelines For Proper Use

What should prescribers and pharmacists check before dispensing Inderal LA?

Confirm the indication and screen for absolute contraindications such as asthma, severe bradycardia, advanced AV block and uncompensated heart failure.

Start low and titrate slowly for elderly patients and those with hepatic impairment, and set realistic expectations that migraine prevention can take several weeks to show effect.

Review concurrent medications for interactions with antihypertensives, certain antidepressants and CYP enzyme inhibitors, and recommend home blood pressure and heart rate monitoring during titration.

Advise patients about CNS effects, the masking of hypoglycaemia in diabetics and the importance of tapering rather than abrupt stopping.

Document the DIN, lot number and counselling in the patient record and provide printed DIN‑specific monograph information and provincial coverage guidance.

Arrange a follow‑up 2–4 weeks after initiation or dose change, then periodically depending on the condition and response.

Delivery Across Canada (English)